Dialyzing Wisely - Improving the Delivery of Acute Renal Replacement Therapy to Albertans (NCT05186636) | Clinical Trial Compass
CompletedNot Applicable
Dialyzing Wisely - Improving the Delivery of Acute Renal Replacement Therapy to Albertans
Canada9,348 participantsStarted 2023-01-12
Plain-language summary
Implementation of an evidence-based and best practices acute RRT pathway aiming to decrease acute RRT program and healthcare systems costs while improving important patient-reported outcomes.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Patient in one of 15 adult and 3 pediatric intensive care units in Alberta Receive acute RRT as part of their usual clinical care during the intervention period
Exclusion Criteria:
* none
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is listed as completed — has any data or results been published yet, and if so, what did it find about how acute kidney injury treatment was being delivered here in Alberta?
2Since this study was measuring 'key performance indicators' for acute renal replacement therapy, does that mean it was looking at how consistently and effectively dialysis is being provided in ICU settings, and could those findings affect how my own treatment might be approached?
3The trial also tracked health system costs for acute dialysis care — does that kind of research ever influence which treatment options are prioritized or made available to patients like me, and should I be aware of that?
4Given that this was a quality-improvement type study rather than a drug or device trial, what does my doctor think it means for my specific situation — would the insights from this research change any recommendations for my acute kidney injury care?
5Are there any current treatment options or protocols for acute renal replacement therapy that my doctor would consider standard of care right now, and how do they compare to whatever improvements this study may have identified?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Key performance indicators (KPI)
Timeframe: Throughout intervention period up to 3 years